Dehydrocorydaline treatment suppresses Th17 differentiation via the mTOR-mediated STAT3-RORγt signaling in systemic lupus erythematosus.

Liu J, Zheng J, Sun Y, Li W, Fu H, Zeng J, Wu H, Meng Y, Liu Y, You D, Cui Y, Tian Z, Hu J, Tang C, Xiao F, Pan T, Lu L, Dang Y, Dai X, Tan H, Ma K

Open source

DOI
10.1186/s10020-026-01435-2
Published
2026 Feb 13
Container
Molecular medicine (Cambridge, Mass.)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s10020-026-01435-2,
  title = {Dehydrocorydaline treatment suppresses Th17 differentiation via the mTOR-mediated STAT3-RORγt signaling in systemic lupus erythematosus.},
  author = {Liu J and Zheng J and Sun Y and Li W and Fu H and Zeng J and Wu H and Meng Y and Liu Y and You D and Cui Y and Tian Z and Hu J and Tang C and Xiao F and Pan T and Lu L and Dang Y and Dai X and Tan H and Ma K},
  year = {2026},
  journal = {Molecular medicine (Cambridge, Mass.)},
  doi = {10.1186/s10020-026-01435-2},
  url = {https://doi.org/10.1186/s10020-026-01435-2}
}

RIS

TY  - JOUR
TI  - Dehydrocorydaline treatment suppresses Th17 differentiation via the mTOR-mediated STAT3-RORγt signaling in systemic lupus erythematosus.
AU  - Liu J
AU  - Zheng J
AU  - Sun Y
AU  - Li W
AU  - Fu H
AU  - Zeng J
AU  - Wu H
AU  - Meng Y
AU  - Liu Y
AU  - You D
AU  - Cui Y
AU  - Tian Z
AU  - Hu J
AU  - Tang C
AU  - Xiao F
AU  - Pan T
AU  - Lu L
AU  - Dang Y
AU  - Dai X
AU  - Tan H
AU  - Ma K
PY  - 2026
JO  - Molecular medicine (Cambridge, Mass.)
DO  - 10.1186/s10020-026-01435-2
UR  - https://doi.org/10.1186/s10020-026-01435-2
ER  - 

APA

J, L., J, Z., Y, S., W, L., H, F., J, Z., H, W., Y, M., Y, L., D, Y., Y, C., Z, T., J, H., C, T., F, X., T, P., L, L., Y, D., X, D., H, T., & K, M. (2026). Dehydrocorydaline treatment suppresses Th17 differentiation via the mTOR-mediated STAT3-RORγt signaling in systemic lupus erythematosus.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-026-01435-2

Source records